000008156 001__ 8156
000008156 005__ 20240725122341.0
000008156 024__ $$aUS 201113071363 A
000008156 024__ $$dUS 8710035 B2
000008156 037__ $$aPATENT
000008156 041__ $$aEnglish
000008156 245__ $$aMethods and compositions related to glucocorticoid receptor antagonists and breast cancer
000008156 260__ $$c2014-04-29
000008156 260__ $$g2011-03-24
000008156 336__ $$aPatent
000008156 520__ $$aEmbodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
000008156 690__ $$aBiological Sciences Division
000008156 691__ $$aMedicine
000008156 7011_ $$aPan, Deng$$uUniversity of Chicago
000008156 7011_ $$aKocherginsky, Masha$$uUniversity of Chicago
000008156 7011_ $$aConzen, Suzanne D.$$uUniversity of Chicago
000008156 7121_ $$aPan, Deng
000008156 7121_ $$aKocherginsky, Masha
000008156 7121_ $$aConzen, Suzanne D.
000008156 7121_ $$aUniversity of Chicago
000008156 7131_ $$aUniversity of Chicago
000008156 8564_ $$9526e4038-6917-4dd4-931d-5645cfa59c68$$ePublic$$s3681998$$uhttps://knowledge.uchicago.edu/record/8156/files/US8710035.pdf
000008156 909CO $$ooai:uchicago.tind.io:8156$$pGLOBAL_SET
000008156 983__ $$aPatent